The commercial approval in June 2006 of the first HPV vaccine, Gardasil (recombinant HPV subtypes 6/11/16/18), marketed by Whitehouse Station, New Jersey–based Merck, has enabled Ian Frazer to ...

Professor Ian Frazer prefers not to dabble in superlatives ... cervical cancer, thanks to Gardasil, a vaccination against the human papilloma virus (HPV) that causes 90% of these cancers.

Ian Frazer, M.D. Director ... Merck licensed the technology from CSL in 1994 and developed Gardasil, the first vaccine for the prevention of cervical cancer. Frazer was named Australian of ...

It was recently announced that Professor Ian Frazer, Director of the University ... the first and only vaccine against cervical cancer. Gardasil, which is distributed by Merck Sharp & Dohme ...